BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17413450)

  • 1. The gene for synapsin III and attention-deficit hyperactivity disorder.
    Makkar R; Gomez L; Wigg KG; Ickowicz A; Pathare T; Tannock R; Malone M; Kennedy JL; Schachar R; Barr CL
    Psychiatr Genet; 2007 Apr; 17(2):109-12. PubMed ID: 17413450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder.
    Barr CL; Wigg KG; Wu J; Zai C; Bloom S; Tannock R; Roberts W; Malone M; Schachar R; Kennedy JL
    Am J Med Genet; 2000 Feb; 96(1):114-7. PubMed ID: 10686563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder.
    Misener VL; Luca P; Azeke O; Crosbie J; Waldman I; Tannock R; Roberts W; Malone M; Schachar R; Ickowicz A; Kennedy JL; Barr CL
    Mol Psychiatry; 2004 May; 9(5):500-9. PubMed ID: 14569274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region.
    Adams J; Crosbie J; Wigg K; Ickowicz A; Pathare T; Roberts W; Malone M; Schachar R; Tannock R; Kennedy JL; Barr CL
    Mol Psychiatry; 2004 May; 9(5):494-9. PubMed ID: 14699423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder.
    Kustanovich V; Merriman B; McGough J; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2003 Mar; 8(3):309-15. PubMed ID: 12660803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage study of the alpha2A adrenergic receptor in attention-deficit hyperactivity disorder families.
    Xu C; Schachar R; Tannock R; Roberts W; Malone M; Kennedy JL; Barr CL
    Am J Med Genet; 2001 Mar; 105(2):159-62. PubMed ID: 11304829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
    Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis.
    Liguori M; Cittadella R; Manna I; Valentino P; La Russa A; Serra P; Trojano M; Messina D; Ruscica F; Andreoli V; Romeo N; Livrea P; Quattrone A
    J Neurol; 2004 Feb; 251(2):165-70. PubMed ID: 14991350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder with or without learning disorder].
    Li J; Wang YF; Zhou RL; Yang L; Zhang HB; Wang B
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2114-8. PubMed ID: 14720417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder.
    Feng Y; Crosbie J; Wigg K; Pathare T; Ickowicz A; Schachar R; Tannock R; Roberts W; Malone M; Swanson J; Kennedy JL; Barr CL
    Mol Psychiatry; 2005 Nov; 10(11):998-1005, 973. PubMed ID: 16088329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D4 receptor gene and attention deficit hyperactivity disorder.
    Frank Y; Pergolizzi RG; Perilla MJ
    Pediatr Neurol; 2004 Nov; 31(5):345-8. PubMed ID: 15519116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD.
    Mill J; Richards S; Knight J; Curran S; Taylor E; Asherson P
    Mol Psychiatry; 2004 Aug; 9(8):801-10. PubMed ID: 15007392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the key directions in the genetics of attention deficit hyperactivity disorder?
    Martin N; McDougall M; Hay DA
    Curr Opin Psychiatry; 2008 Jul; 21(4):356-61. PubMed ID: 18520740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB.
    Ribasés M; Ramos-Quiroga JA; Hervás A; Bosch R; Bielsa A; Gastaminza X; Artigas J; Rodriguez-Ben S; Estivill X; Casas M; Cormand B; Bayés M
    Mol Psychiatry; 2009 Jan; 14(1):71-85. PubMed ID: 17938636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polymorphisms in serotonin 2C receptor gene and attention-deficit/hyperactivity disorder in Han Chinese subjects.
    Li J; Wang Y; Zhou R; Zhang H; Yang L; Wang B; Faraone SV
    Neurosci Lett; 2006 Oct; 407(2):107-11. PubMed ID: 16959425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders.
    Dempster EL; Burcescu I; Wigg K; Kiss E; Baji I; Gadoros J; Tamás Z; Kennedy JL; Vetró A; Kovacs M; Barr CL
    Arch Gen Psychiatry; 2007 Oct; 64(10):1189-95. PubMed ID: 17909131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the dopamine D5 receptor gene (DRD5) in adult attention deficit hyperactivity disorder.
    Squassina A; Lanktree M; De Luca V; Jain U; Krinsky M; Kennedy JL; Muglia P
    Neurosci Lett; 2008 Feb; 432(1):50-3. PubMed ID: 18164132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No causal role for the G482T and G689T polymorphisms in translation regulation of serotonin transporter (SLC6A4) or association with attention-deficit-hyperactivity disorder (ADHD).
    Banerjee E; Sinha S; Chatterjee A; Nandagopal K
    Neurosci Lett; 2009 May; 454(3):244-8. PubMed ID: 19429092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.